Queen Square Centre for Neuromuscular Diseases


International Inclusion Body Myositis (IBM) Genetics Consortium reaches 750 samples

1 July 2020

The International muscle consortium led by the UCL Institute of Neurology reaches 750 Inclusion Body Myositis (IBM) patients, and aims for 1,000 patients to donate a blood sample for a groundbreaking genome wide study to understand the disease pathways in this disorder and accelerate therapeutics.

Helix DNA

If you would like to participate, please contact: p.machado@ucl.ac.uk, iwona.skorupinska@nhs.net and n.dominik@ucl.ac.uk.